All In Biotech

Free tool

FAERS Monitor: Sancuso

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022198 or its brand name (Sancuso, Granisetron). Reports on generic versions are filed under their own applications.

Reports

10,458

Serious

8,771

84% of reports

Hospitalization

5,106

Death reported

1,879

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea1,337
  • vomiting768
  • febrile neutropenia741
  • diarrhoea728
  • pyrexia664
  • death611
  • dyspnoea605
  • fatigue570
  • neutropenia492
  • anaemia491
  • off label use461
  • constipation404
  • product adhesion issue399
  • decreased appetite381
  • pneumonia376

Reports by year received

View as table
YearReports
2004129
2005106
200660
200774
200863
200954
2010129
2011250
2012626
2013392
2014446
2015481
2016829
2017686
2018859
2019943
2020871
2021834
2022831
2023528
2024461
2025495
2026310

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,701 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal74122.721.215,233
product adhesion issueSignal39922.720.68,177
neutropeniaSignal4927.36.72,676
anaemiaSignal4915.24.81,667
pyrexiaSignal6643.93.61,428
constipationSignal4043.73.4812
nauseaSignal1,3373.43.22,349
decreased appetiteSignal3813.33.0615
vomitingSignal7683.33.11,247
pneumoniaSignal3762.32.1290
diarrhoeaSignal7282.32.1532
dyspnoeaSignal6052.22.0381
fatigue5701.51.489
death6111.41.381
off label use4611.11.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.